Abstract
Objective: To observe the effect of Xueshuantong injection (XST, with its ingredient as Notoginseng saponin, on acute cerebral infarction (ACI) and on blood coagulation and fibrinolysis, so as to comprehensively analyse the mechanism of XST.Methods: Fifty ACI patients were randomly divided into 2 groups, and XST group (30 patients) was treated with XST, and the control group (20 patients) given low molecular dextrose, as well as low molecular heparin calcium. The course of treatment for both groups was 15 days. The changes of effective rate, score of neurologic impairment, tissuetype plasminogen activator (tPA), inhibitor of plasminogen activator (PAI), D-D dimmer, antithrombinIII (AT-III), and fibrinogen (Fbg) were all observed.Results: The total effective rate of XST group was 73.33%, that of the control group 65. 00%. After the therapy, plasma level of tPA, ratio of tPA/PAI, and AT-III content were increased obviously, while the plasma level of PAI and D-D dimmer were decreased significantly (all P<0.01). But there was only insignificant difference between the 2 groups (P> 0.05).Conclusion: XST injection could be effective to ACI, the mechanism of which is probably related to improving the balance between plasminogen activator and its inhibitory factor, increasing the activity of fibrinolysin, inactivating thrombin, inhibiting platelet aggregation induced by thrombin, and decreasing blood coagulation.
Similar content being viewed by others
References
SONG HB, MENG SQ, GAO QJ. Therapeutic effect of Notoginseng saponin injection in treating acute onset stage heart failure of cor pulmonale. Chin J Integ Trad West Med Emerg 1999; 6 (11): 507–509.
XIONG YH, PI ZJ, QIAN LZ, et al. Comparative observation of Notoginseng saponin and low molecule dextran in treating cerebral infarction. J Stroke Neurolog Dis 1998;5(3): 165–166.
Chinese Association of Neurology, Chinese Association of Neurosurgery. Main diagnostic points of various cerebrovascular diseases. Chin J Neurology 1996; 29(6): 379–381.
Adams H, Bendixen BH, Kapelle LT, et al. Classification of subtype of acute ischemic stroke. Stroke 1993;24(1): 99–101.
WANG XD. Suggestions on clinical study of cerebral stroke. Chin J Neurolog Psychia 1988;21(1): 57–60.
CHEN DR, SHI YM, TIAN GQ, et al. Comparative study of Ligustrazine and low molecule dextran in treating acute cerebral infarction. Chin J Integra Tradi West Med (Chin) 1992; 12(2): 71–73.
TAN MX, WEI GZ, WANG XD. Suggestions on the treatment of acute ischemic cerebral stroke patients. Chin J Neurolog Psychiatr 1998;24(5): 315–316.
SHI XH, HAN CY, TIAN SL, et al. Study on plasma tPA, PAI activity of cerebral thrombosis patients. Chin J Neurolog Psychiatr 1992;25: 260.
Feinberg WM, Bruck DC, Ring ME, et al. Hemostatic markers in acute stroke. Stroke 1989;20(2): 592–594.
GAO YQ, XIE XF, WANG XF, et al. The clinical significance of plasma D-dipoid determination of acute cerebrovascular diseases. J Clin Neurolog 1996; 9(4): 209.
ZHANG JL, HE ML. Effect of before and after intravenous thrombolytic treatment on blood coagulation and fibrinolytic system. J Stroke Neurolog Dis 1999; 16(1): 35–36.
LU J. Analysis of preliminary determination on anti-thrombin-III and fibrinogen of acute cerebrovascular disease. Chin J Neurolog 1989;22: 205–206.
MA X. Observation on fibrinogen molecule reactivity of ischemic cardio-cerebrovascular disease. Chin J Hematolog 1996; 17(3): 135.
Willhemsen L. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984;311:501.
MA BS, CHANG JM. General survey on integrative Chinese and western medicine in treating cerebrovascular disease, Chin J Chin Wes Med Emerg 1995; 2(6): 286–287.
LI LX, WANG ZC, LI YY, et al. Protection of Notoginseng saponin D1 on rabbit acute ischemia. Chin Pharmacolog Acad J 1991;7(5): 350–353.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jin-hang, D., Zai-fang, R., Zai-xiang, S. et al. Clinical studies on treatment of acute cerebral infarction with Xueshuantong injection. Chin. J. Integr. Med. 9, 21–24 (2003). https://doi.org/10.1007/BF02836348
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02836348